Tokyo Tape
Sign in
← Torii Pharmaceutical

Annual report

4551.TEDINET S100VH2F
Period2024-01-01 → 2024-12-31
Filed2025-03-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 89
MetricValuePeriodScopeSource row
Revenue¥60.4bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥54.6bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥48.9bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥47.0bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥41.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income¥6.8bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income¥5.0bn2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income¥6.9bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income¥5.3bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥5.5bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥4.8bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥6.7bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax¥5.6bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥5.0bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income¥4.1bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥3.9bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.4bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.5bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥140.7bnat 2024-12-31StandaloneAssets
Total assets¥133.4bnat 2023-12-31StandaloneAssets
Total assets¥133.7bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥130.8bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥126.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥19.1bnat 2024-12-31StandaloneLiabilities
Total liabilities¥13.3bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥121.5bnat 2024-12-31StandaloneNet assets
Net assets / equity¥120.1bnat 2023-12-31StandaloneNet assets
Net assets / equity¥119.2bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥117.0bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥115.1bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.3bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥5.0bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥30.8bnat 2024-12-31StandaloneCash and cash equivalents
Cash & equivalents¥34.7bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥45.4bnat 2022-12-31dStandaloneCash and cash equivalents
Cash & equivalents¥58.4bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥61.6bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥3.6bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥3.1bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥2.4bn2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥156m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥3.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥3.6bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥3.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥13.7bn2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.5bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥7.6bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥3.9bn2024-01-01 → 2024-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥3.8bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥1.7bn2022-01-01 → 2022-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.5bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥1.4bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥179.382024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥146.62023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥140.392022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥120.132021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥124.472020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥124.462020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1202024-01-01 → 2024-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1202023-01-01 → 2023-12-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1002022-01-01 → 2022-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482021-01-01 → 2021-12-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥482020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥4,323.33at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,274.45at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥4,243.08at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,165.38at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥4,097.55at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio86.4%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.0%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio89.2%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio89.5%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE4.2%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE3.4%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE3.3%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE2.9%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE3.1%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued28,800,000at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued28,800,000at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees592at 2024-12-31StandaloneNumber of employees
Employees583at 2023-12-31StandaloneNumber of employees
Employees563at 2022-12-31dStandaloneNumber of employees
Employees560at 2021-12-31dStandaloneNumber of employees
Employees568at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 1
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2024-12-31592 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 974
ItemContextValueUnit
Net assetsCurrentYearInstant_NonConsolidatedMember121533000000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember133432000000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember140664000000JPY
Net sales of goods rev oaPrior1YearDuration_NonConsolidatedMember24960000000JPY
Net sales of goods rev oaCurrentYearDuration_NonConsolidatedMember27083000000JPY
Net sales of finished goods rev oaPrior1YearDuration_NonConsolidatedMember29378000000JPY
Net sales of finished goods rev oaCurrentYearDuration_NonConsolidatedMember33061000000JPY
Other sales rev oaPrior1YearDuration_NonConsolidatedMember299000000JPY
Other sales rev oaCurrentYearDuration_NonConsolidatedMember281000000JPY
Net salesPrior1YearDuration_NonConsolidatedMember54638000000JPY
Net salesCurrentYearDuration_NonConsolidatedMember60426000000JPY
Beginning merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember6165000000JPY
Beginning merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember6827000000JPY
Cost of purchased goodsPrior1YearDuration_NonConsolidatedMember14333000000JPY
Cost of purchased goodsCurrentYearDuration_NonConsolidatedMember17831000000JPY
Cost of products manufacturedPrior1YearDuration_NonConsolidatedMember16126000000JPY
Cost of products manufacturedCurrentYearDuration_NonConsolidatedMember19656000000JPY
Total beginning and cost purchased merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember36625000000JPY
Total beginning and cost purchased merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember44315000000JPY
Transfer to other account cosPrior1YearDuration_NonConsolidatedMember12000000JPY
Transfer to other account cosCurrentYearDuration_NonConsolidatedMember5000000JPY
Ending merchandise and finished goods cosPrior1YearDuration_NonConsolidatedMember6827000000JPY
Ending merchandise and finished goods cosCurrentYearDuration_NonConsolidatedMember10650000000JPY
Net cos merchandise and finished goodsPrior1YearDuration_NonConsolidatedMember29786000000JPY
Net cos merchandise and finished goodsCurrentYearDuration_NonConsolidatedMember33659000000JPY
Other cost cos exp oaPrior1YearDuration_NonConsolidatedMember60000000JPY
Other cost cos exp oaCurrentYearDuration_NonConsolidatedMember59000000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember29847000000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember33719000000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember24791000000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember26707000000JPY
Promotion expenses sgaPrior1YearDuration_NonConsolidatedMember1582000000JPY
Promotion expenses sgaCurrentYearDuration_NonConsolidatedMember1960000000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember4715000000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember4535000000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember374000000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember411000000JPY
Retirement benefit expenses sgaPrior1YearDuration_NonConsolidatedMember72000000JPY
Retirement benefit expenses sgaCurrentYearDuration_NonConsolidatedMember68000000JPY
License fee sgaPrior1YearDuration_NonConsolidatedMember2033000000JPY
License fee sgaCurrentYearDuration_NonConsolidatedMember2290000000JPY
Commission sgaPrior1YearDuration_NonConsolidatedMember2154000000JPY
Commission sgaCurrentYearDuration_NonConsolidatedMember2254000000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember218000000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember202000000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember3490000000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember2824000000JPY
Other sgaPrior1YearDuration_NonConsolidatedMember5112000000JPY
Other sgaCurrentYearDuration_NonConsolidatedMember5362000000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember19755000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass